Minitran Interactions
There are 257 drugs known to interact with Minitran (nitroglycerin), along with 8 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 10 are major, 219 are moderate, and 28 are minor.
- View all 257 medications that may interact with Minitran
- View Minitran alcohol/food interactions (1)
- View Minitran disease interactions (8)
Most frequently checked interactions
View interaction reports for Minitran (nitroglycerin) and the medicines listed below.
- allopurinol
- alprazolam
- amlodipine
- Aspir 81 (aspirin)
- aspirin
- Aspirin Low Strength (aspirin)
- Atorvaliq (atorvastatin)
- atorvastatin
- bisacodyl
- calcitriol
- calcium carbonate
- clopidogrel
- Crestor (rosuvastatin)
- escitalopram
- furosemide
- lactulose
- Lasix (furosemide)
- Lipitor (atorvastatin)
- lisinopril
- metformin
- metoprolol
- Norvasc (amlodipine)
- omeprazole
- pantoprazole
- Paracetamol (acetaminophen)
- Plavix (clopidogrel)
- Ranexa (ranolazine)
- Ravin (glycerin)
- simvastatin
- Unasyn (ampicillin / sulbactam)
Minitran alcohol/food interactions
There is 1 alcohol/food interaction with Minitran (nitroglycerin).
Minitran disease interactions
There are 8 disease interactions with Minitran (nitroglycerin) which include:
- AMI
- anemia
- hemodialysis
- hypotension
- intracranial pressure
- pericarditis
- hypertrophic cardiomyopathy
- glaucoma
Report options
QR code containing a link to this page
More about Minitran (nitroglycerin)
- Minitran consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: antianginal agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.